SCHEMBL3915993

SCHEMBL3915993

C=CC(=O)OC[SiH2]C(OC)OC

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.47
HPGD P15428 1/20 0.41
ALDH1A1 P00352 4/20 0.41
TP53 P04637 3/20 0.41
HIF1A Q16665 3/20 0.41
CYP3A4 P08684 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
THRB P10828 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733860 0.81 TSHR (0.47) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL3915278 0.81 TSHR (0.48) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL3914586 0.81 TSHR (0.44) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL6037080 0.81 TSHR (0.41) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL3923715 0.81 TSHR (0.41) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL397012 0.80 TSHR (0.43) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL140890 0.79 TSHR (0.53) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL15864750 0.79 TSHR (0.49) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL16538074 0.78 TSHR (0.56) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL16538045 0.77 TSHR (0.52) TSHRHPGDALDH1A1TP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6841694-B2 Process for stabilizing unsaturated organosilicon compounds WACKER-CHEMIE GMBH (DE) 2005-01-11 US claimed
US-20040171859-A1 Process for stabilizing unsaturated organosilicon compounds WACKER-CHEMIE GMBH (DE) 2004-09-02 US claimed
EP-4129682-B1 A LITHOGRAPHIC PRINTING PLATE PRECURSOR ECO3 BV (BE) 2025-10-01 EP disclosed
CN-113423794-B Curable composition 株式会社钟化 2023-12-08 CN disclosed
CN-117015561-A (meth) acrylate copolymer and curable composition 株式会社钟化 2023-11-07 CN disclosed
CN-116997610-A Curable composition and cured product thereof 株式会社钟化 2023-11-03 CN disclosed
CN-114207017-B Curable composition 株式会社钟化 2023-06-20 CN disclosed
CN-115916855-A (meth) acrylate copolymer and curable composition thereof 株式会社钟化 2023-04-04 CN disclosed
CN-111533854-B Silicon modified acrylic resin and application thereof 上海亿祺化工技术有限公司 2023-03-31 CN disclosed
CN-113728056-B Latent heat storage material 株式会社钟化 2023-03-24 CN disclosed
CN-112424269-B Resin composition for foam, and method for producing foam 株式会社钟化 2023-02-28 CN disclosed
CN-104884552-A ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM BASF COATINGS GMBH 2015-09-02 CN disclosed
US-20150065639-A1 CONJUGATED DIENE RANDOM COPOLYMER HAVING ALKOXYSILANE UNIT KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2015-03-05 US disclosed
WO-2014106552-A1 ONE -COMPONENT, CURABLE COATING COMPOSITION, PROCESSES FOR MAKING AND USING THEM, AND COATINGS AND ARTICLES PREPARED WITH THEM BASF COATINGS GMBH (DE) 2014-07-10 WO disclosed
US-7619108-B2 Process for preparing unsaturated organosilicon compounds WACKER CHEMIE AG (DE) 2009-11-17 US disclosed
EP-1954701-B1 PROCESS FOR PREPARING UNSATURATED ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2009-03-18 EP disclosed
US-20080293958-A1 Process for Preparing Unsaturated Organosilicon Compounds WACKER CHEMIE AG (DE) 2008-11-27 US disclosed
US-6815554-B2 REACTING A HALOALKYLSILANE WITH A SALT OF AN UNSATURATED CARBOXYLIC ACID IN THE PRESENCE OF A PHASE TRANSFER CATALYST; BONDING AGENTS WACKER-CHEMIE GMBH (DE) 2004-11-09 US disclosed
US-20020151736-A1 PROCESS FOR PREPARING UNSATURATED ORGANOSILICON COMPOUNDS WACKER-CHEMIE GMBH (DE) 2002-10-17 US disclosed
EP-1249454-A1 Preparation of unsaturated organo-silicon compounds Wacker-Chemie GmbH (DE) 2002-10-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171859-A1 Process for stabilizing unsaturated organosilicon compounds ELOVL1, ELOVL6, DEGS1 TSHR 4650/4885HPGD 1893/4885ALDH1A1 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.